A $193 million award against Eli Lilly and Co. in a False Claims Act suit alleging Medicaid fraud will stand, the Seventh Circuit ruled Thursday.
The US Court of Appeals for the Seventh Circuit rejected several challenges to the 2023 award, including the company’s argument that it had an objectively reasonable interpretation of drug price calculation requirements.
Whistleblower Ronald J. Streck filed the suit in 2014 alleging abuse of Medicaid’s drug rebate program, under which the rebates drugmakers are required to pay are based on average manufacturer prices submitted to the government.
Streck showed that Eli Lilly’s calculations and ...
Popular right wing influencer Charlie Kirk was killed in a shooting in Utah yesterday, rocking the nation and spurring debate over the role of divisive rhetoric in political violence. As is often ...